A new trading day began on Monday, with Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock price down -5.77% from the previous day of trading, before settling in for the closing price of $67.79. ARWR’s price has ranged from $9.57 to $72.36 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 57.10% over the past five years. Meanwhile, its annual earnings per share averaged -31404.38%. With a float of $125.92 million, this company’s outstanding shares have now reached $135.70 million.
Arrowhead Pharmaceuticals Inc (ARWR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Arrowhead Pharmaceuticals Inc is 7.28%, while institutional ownership is 81.17%. The most recent insider transaction that took place on Jan 05 ’26, was worth 3,123,349. In this transaction COO of this company sold 49,493 shares at a rate of $63.11, taking the stock ownership to the 474,908 shares. Before that another transaction happened on Jan 05 ’26, when Company’s Chief Medical Officer sold 40,164 for $63.11, making the entire transaction worth $2,534,661. This insider now owns 171,958 shares in total.
Arrowhead Pharmaceuticals Inc (ARWR) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -1.39 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.08 per share during the current fiscal year.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Trading Performance Indicators
Here are Arrowhead Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.46. Likewise, its price to free cash flow for the trailing twelve months is 55.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.07, a number that is poised to hit 0.12 in the next quarter and is forecasted to reach -4.31 in one year’s time.
Technical Analysis of Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) saw its 5-day average volume 1.43 million, a negative change from its year-to-date volume of 1.93 million. As of the previous 9 days, the stock’s Stochastic %D was 35.17%.
During the past 100 days, Arrowhead Pharmaceuticals Inc’s (ARWR) raw stochastic average was set at 84.37%, which indicates a significant increase from 37.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.43 in the past 14 days, which was higher than the 2.45 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $53.60, while its 200-day Moving Average is $28.40. Nevertheless, the first resistance level for the watch stands at $67.91 in the near term. At $71.94, the stock is likely to face the second major resistance level. The third major resistance level sits at $75.58. If the price goes on to break the first support level at $60.24, it is likely to go to the next support level at $56.59. The third support level lies at $52.56 if the price breaches the second support level.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Key Stats
With a market capitalization of 8.68 billion, the company has a total of 135,880K Shares Outstanding. Currently, annual sales are 829,450 K while annual income is -1,630 K. The company’s previous quarter sales were 256,470 K while its latest quarter income was -23,750 K.
